Clinical Trials in North Carolina

Showing 641-660 of 17,526 trials

CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)

NCT05897632

The goal of this study is to determine if rapid outpatient evaluation vs hospitalization management is the best strategy (based on patient-centered measures and safe, equitable, and efficient resource use) for evaluating patients with acute chest pain who are at moderate risk for acute coronary syndrome (ACS). Patients will be randomized in the Emergency Department to either an outpatient evaluation (CARE-CP) or hospitalization evaluation for their symptoms.

Chest Pain

Wake Forest University Health Sciences502 participantsStarted Oct 2023

Detroit, Michigan, United States • Charlotte, North Carolina, United States • Winston-Salem, North Carolina, United States

RECRUITINGPhase 341 miles

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

NCT07361497

A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer (NSCLC)

Bristol-Myers Squibb850 participantsStarted Mar 2026

Daphne, Alabama, United States • Chandler, Arizona, United States • Golden, Colorado, United States +252 more locations

CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Find Trials by Condition in North Carolina

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI?

A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Women's Heart Attack Research Program: Stress Ancillary Study

RCT to Evaluate Social Skills in Children With Autism Using VR Technology (SoCaVR)

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration